A Chlorotoxin‐Directed Diselenide‐Bridged Tumor‐Homing Persistent Luminescence Nanoprobes Mediating Inhibition of Oxidative Phosphorylation for Long‐Term Near‐Infrared Imaging and Therapy of Glioblastoma (Adv. Funct. Mater. 1/2023)

Glioblastoma Targeted Therapy In article number 2209579, Wang and co‐workers report a near‐infrared persistent luminescence nanoparticle for the diagnosis and targeted therapy of glioblastoma (GBM). GBM cell membrane (GCM) coating and chlorotoxin enhanced the blood‐brain barrier (BBB) penetration an...

Full description

Saved in:
Bibliographic Details
Published inAdvanced functional materials Vol. 33; no. 1
Main Authors Kong, Jianglong, Sun, Yuting, Ge, Xiaohan, Mao, Meiru, Yu, Hongrui, Wang, Yi
Format Journal Article
LanguageEnglish
Published 03.01.2023
Subjects
blood–brain barriers
diselenides
glioblastoma
imaging
near‐infrared
persistent luminescence
therapies
Online AccessGet full text

Cover

More Information
Summary:Glioblastoma Targeted Therapy In article number 2209579, Wang and co‐workers report a near‐infrared persistent luminescence nanoparticle for the diagnosis and targeted therapy of glioblastoma (GBM). GBM cell membrane (GCM) coating and chlorotoxin enhanced the blood‐brain barrier (BBB) penetration and the targeting and tumor‐homing of GBM. This study offers an example of the highly promising drug carriers for precise diagnosis and therapy of central nervous system diseases.
ISSN:1616-301X
1616-3028
DOI:10.1002/adfm.202370008